The molecular basis of Boston-type craniosynostosis: the Pro148-->His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences
about
The molecular basis of Rieger syndrome. Analysis of Pitx2 homeodomain protein activitiesMutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouseHaploinsufficiency of ALX4 as a potential cause of parietal foramina in the 11p11.2 contiguous gene-deletion syndromeLoss of Smad3-mediated negative regulation of Runx2 activity leads to an alteration in cell fate determinationMarshall syndrome associated with a splicing defect at the COL11A1 locus.Enlarged parietal foramina caused by mutations in the homeobox genes ALX4 and MSX2: from genotype to phenotypeCraniosynostosis in transgenic mice overexpressing Nell-1Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studiesA Genetic-Pathophysiological Framework for CraniosynostosisRegulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiationTgf-beta1, Tgf-beta2, Tgf-beta3 and Msx2 expression is elevated during frontonasal suture morphogenesis and during active postnatal facial growthTransforming growth factor-beta3 (Tgf-beta3) down-regulates Tgf-beta3 receptor type I (Tbetar-I) during rescue of cranial sutures from osseous obliterationBone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests.MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling.The impact of molecular genetics on oral health paradigms.Missense mutations in the homeodomain of HOXD13 are associated with brachydactyly types D and E.Characterization of a new syndrome that associates craniosynostosis, delayed fontanel closure, parietal foramina, imperforate anus, and skin eruption: CDAGS.Characterization of distinct classes of differential gene expression in osteoblast cultures from non-syndromic craniosynostosis boneEctodermal dysplasias: not only 'skin' deep.Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro.Molecular basis of cranial suture biology and disease: Osteoblastic and osteoclastic perspectivesPITX2 gain-of-function in Rieger syndrome eye model.Genetically altered mouse models: the good, the bad, and the ugly.A homeodomain transcription factor gene, PfMSX, activates expression of Pif gene in the pearl oyster Pinctada fucataSignaling pathways in osteogenesis and osteoclastogenesis: Lessons from cranial sutures and applications to regenerative medicine.Msx homeobox gene family and craniofacial development.Cytokine therapy for craniosynostosis.Signaling networks that control the lineage commitment and differentiation of bone cells.MSX2 copy number increase and craniosynostosis: copy number variation detected by array comparative genomic hybridization.Structural basis of an embryonically lethal single Ala --> Thr mutation in the vnd/NK-2 homeodomainSignaling and transcriptional regulation in osteoblast commitment and differentiationMsx2 exerts bone anabolism via canonical Wnt signaling.Homeobox protein MSX2 acts as a molecular defense mechanism for preventing ossification in ligament fibroblasts.Noonan syndrome is associated with enhanced pERK activity, the repression of which can prevent craniofacial malformations.Frontonasal Dysplasia: Towards an Understanding of Molecular and Developmental Aetiology.Craniosynostosis genetics: The mystery unfolds.Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter.Haploinsufficiency of MSX1: a mechanism for selective tooth agenesis.
P2860
Q24318726-21A3D526-A749-4A52-88A7-9C8E0630D806Q24323305-50694F1C-6F06-4706-9B02-8F7A88E295DAQ24534695-5F1C5DAF-65D0-4725-ABAD-9504D9F4C297Q24534967-B3DCFBA4-86A3-4F5E-987C-338F9DA3FD9FQ24538872-D0164D4F-F2E5-484A-8065-8691551E7B44Q24548200-13451FDC-CAAD-469B-B081-DDD4CA19BED9Q24553230-F695FB4C-900F-4FAF-872B-767C97B279E7Q24675596-6E13FCE4-D70C-48D1-83B1-3BE5DD6F888DQ26784240-E06A5CC3-A196-40EB-BD09-90069B03CCAFQ28202583-48A6378B-CDEF-4DD7-A2CE-2B8DE7AD1EC5Q28513083-B3EB6E64-5369-4C0B-8E87-74A2322B0E75Q28567708-30AE6A85-243C-4F7E-B018-C02948565F55Q28578731-BF44AAA3-7835-4513-9DBB-BFABB3D4C3AEQ28586077-67DDA462-220B-482E-8D1C-5D8491CD37AAQ29248402-2E474E3B-17AB-43C7-8A6F-65AA565D01A4Q33361639-BBE9667A-08FC-4CDE-BEE9-F78FB7EB968EQ33842939-3BCA6861-3C90-4536-B6D5-923A7E30D20DQ33905134-0866B3C2-28C1-4F02-A603-4CA259F8AE77Q34021053-2E392AED-269E-4BA4-B8A4-C9545DD0E74AQ34112919-CD6BCD6E-A97D-4B19-89A0-56E7807DF716Q34125646-8076D266-AD75-480B-A1AB-DA7327957A00Q34173527-52DBA702-A0B9-40C7-A77D-5690D1335C67Q34560898-F60396D7-C0D7-4E9C-8E85-66733B2B84C2Q35103384-B7F53087-AA1D-4789-9A46-5E238EDB0C7BQ35150807-F1059FC8-F0CA-4923-9F09-A8192FA6CA05Q35220483-D9AE5E4E-C637-4809-AF46-3AABA8726BD8Q35587493-146B75AE-E277-4A01-81AE-5AB23232336FQ35631682-D1497CA7-2F25-46FC-B27F-5959D044B47FQ35684846-37AFF985-EB40-49C3-B12F-CE7588A2FB60Q36082866-7A6276B1-3844-43AC-B697-5E246274EC62Q36157171-5CC080FE-3907-416E-9E50-1C394BA0619BQ36489640-7E2F8442-A44A-4AF6-A9C5-61442162184FQ36606452-A378E696-85A1-4EA6-AF23-422BBDD05808Q36761867-BFCDB0ED-D9AB-4CEE-81FC-CE0F30B9A641Q37277732-2CB0773B-A8B7-4E7C-9B0E-9E8391FC6976Q37340867-DE2FE24D-25A0-424B-B0BB-9E214AEB55B8Q37460161-932D3408-D856-473E-A457-36D6C4908A9BQ37957083-B980CD0A-5EB0-47B8-9BB6-7DF53CC01373Q38321841-86FEFE74-31D9-45F8-A6FE-DBEB9DBA6EFEQ39576280-5EE3D18F-9056-40CC-A50C-C502E19DC99D
P2860
The molecular basis of Boston-type craniosynostosis: the Pro148-->His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The molecular basis of Boston- ...... ucleotide sequence preferences
@ast
The molecular basis of Boston- ...... ucleotide sequence preferences
@en
The molecular basis of Boston- ...... ucleotide sequence preferences
@en-gb
The molecular basis of Boston- ...... ucleotide sequence preferences
@nl
type
label
The molecular basis of Boston- ...... ucleotide sequence preferences
@ast
The molecular basis of Boston- ...... ucleotide sequence preferences
@en
The molecular basis of Boston- ...... ucleotide sequence preferences
@en-gb
The molecular basis of Boston- ...... ucleotide sequence preferences
@nl
prefLabel
The molecular basis of Boston- ...... ucleotide sequence preferences
@ast
The molecular basis of Boston- ...... ucleotide sequence preferences
@en
The molecular basis of Boston- ...... ucleotide sequence preferences
@en-gb
The molecular basis of Boston- ...... ucleotide sequence preferences
@nl
P2093
P921
P356
P1476
The molecular basis of Boston- ...... ucleotide sequence preferences
@en
P2093
P304
P356
10.1093/HMG/5.12.1915
P407
P577
1996-12-01T00:00:00Z